Diana Johnson – 2015 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Diana Johnson on 2015-12-14.

To ask the Secretary of State for Health, what guidance his Department has issued to (a) clinical commissioning groups, (b) hospital trusts and (c) health and well-being boards on BRCA gene testing for (i) patients who have been diagnosed with ovarian cancer and (ii) people identified as likely to have the BRCA gene mutation due to their family history.

Jane Ellison

NHS England published a new Clinical Commissioning Policy on Genetic Testing for BRCA1/2 mutations in July 2015, based on updated guidelines issued by the National Institute for Health and Care Excellence. This policy applies to patients diagnosed with ovarian cancer and people likely to have the BRCA gene mutation due to their family history.